NO975238L - Muskeltrofisk faktor - Google Patents
Muskeltrofisk faktorInfo
- Publication number
- NO975238L NO975238L NO975238A NO975238A NO975238L NO 975238 L NO975238 L NO 975238L NO 975238 A NO975238 A NO 975238A NO 975238 A NO975238 A NO 975238A NO 975238 L NO975238 L NO 975238L
- Authority
- NO
- Norway
- Prior art keywords
- muscular
- methods
- preparations
- trophic factor
- farm
- Prior art date
Links
- 230000003387 muscular Effects 0.000 title abstract 2
- 230000001228 trophic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 102000003812 Interleukin-15 Human genes 0.000 abstract 1
- 108090000172 Interleukin-15 Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000013372 meat Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000037257 muscle growth Effects 0.000 abstract 1
- 201000006938 muscular dystrophy Diseases 0.000 abstract 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/535,733 US5660824A (en) | 1995-05-24 | 1995-05-24 | Muscle trophic factor |
| PCT/US1996/006423 WO1996037223A1 (en) | 1995-05-24 | 1996-05-07 | Muscle trophic factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975238D0 NO975238D0 (no) | 1997-11-14 |
| NO975238L true NO975238L (no) | 1998-01-23 |
Family
ID=24135542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975238A NO975238L (no) | 1995-05-24 | 1997-11-14 | Muskeltrofisk faktor |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5660824A (ko) |
| EP (1) | EP0831902A4 (ko) |
| JP (1) | JPH11505836A (ko) |
| KR (1) | KR19990014835A (ko) |
| AU (1) | AU705609B2 (ko) |
| CA (1) | CA2221148C (ko) |
| NO (1) | NO975238L (ko) |
| NZ (1) | NZ307845A (ko) |
| WO (1) | WO1996037223A1 (ko) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4128625B2 (ja) | 1995-10-17 | 2008-07-30 | ウェイン ステイト ユニヴァーシティ | チキンインターロイキン−１５及びその使用 |
| US6511848B2 (en) * | 1996-04-17 | 2003-01-28 | Winfried Albert | Process for producing and multiplying lymphocytes |
| US6087172A (en) * | 1997-10-31 | 2000-07-11 | Hisamitsu Pharmaceutical Co., Inc. | Ribozymes targeted to human IL-15 mRNA |
| US6828147B1 (en) | 1999-02-24 | 2004-12-07 | The Wistar Institute Of Anatomy And Biology | Method of modifying cytotoxic cells and uses thereof |
| US6750194B1 (en) | 2000-10-23 | 2004-06-15 | The Procter & Gamble Company | Methods of identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| US6670140B2 (en) | 2001-03-06 | 2003-12-30 | The Procter & Gamble Company | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| US7247304B2 (en) * | 2001-08-23 | 2007-07-24 | Genmab A/S | Methods of treating using anti-IL-15 antibodies |
| US7329405B2 (en) * | 2001-08-23 | 2008-02-12 | Genmab A/S | Human antibodies specific for interleukin 15 (IL-15) |
| SI1425389T1 (sl) * | 2001-08-23 | 2012-02-29 | Genmab As | Humana protitelesa, specifična za interlevkin 15 (IL-15) |
| US7192924B2 (en) | 2002-01-16 | 2007-03-20 | The Procter & Gamble Company | Corticotropin releasing factor 2 receptor agonists |
| MX2007014474A (es) | 2005-05-17 | 2008-02-07 | Univ Connecticut | Composiciones y metodos para inmunomodulacion en un organismo. |
| NZ596494A (en) | 2006-01-13 | 2013-07-26 | Us Gov Nat Inst Health | Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells |
| ES2466916T3 (es) | 2007-06-27 | 2014-06-11 | Admune Therapeutics Llc | Complejos de IL-15 e IL-15R alfa y usos de los mismos |
| WO2009135031A1 (en) | 2008-04-30 | 2009-11-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Substituted il-15 |
| JP2013501817A (ja) | 2009-08-14 | 2013-01-17 | アメリカ合衆国 | 胸腺産出の増大およびリンパ球減少症の治療のためのｉｌ−１５の使用 |
| AU2016305490B2 (en) | 2015-08-07 | 2022-07-14 | Commonwealth Scientific And Industrial Research Organisation | Method for producing an animal comprising a germline genetic modification |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4448879A (en) * | 1981-03-26 | 1984-05-15 | Hooper Trading Company | High yield process for in vitro production of serum-free and mitogen-free interleukin-2 |
-
1995
- 1995-05-24 US US08/535,733 patent/US5660824A/en not_active Expired - Lifetime
-
1996
- 1996-05-07 EP EP96915558A patent/EP0831902A4/en not_active Withdrawn
- 1996-05-07 AU AU57307/96A patent/AU705609B2/en not_active Ceased
- 1996-05-07 WO PCT/US1996/006423 patent/WO1996037223A1/en not_active Application Discontinuation
- 1996-05-07 JP JP8535693A patent/JPH11505836A/ja active Pending
- 1996-05-07 CA CA002221148A patent/CA2221148C/en not_active Expired - Fee Related
- 1996-05-07 KR KR1019970708179A patent/KR19990014835A/ko not_active Application Discontinuation
- 1996-05-07 NZ NZ307845A patent/NZ307845A/en unknown
-
1997
- 1997-11-14 NO NO975238A patent/NO975238L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ307845A (en) | 1999-10-28 |
| JPH11505836A (ja) | 1999-05-25 |
| MX9708853A (es) | 1998-03-31 |
| CA2221148A1 (en) | 1996-11-28 |
| AU5730796A (en) | 1996-12-11 |
| CA2221148C (en) | 2000-10-24 |
| EP0831902A4 (en) | 2002-04-17 |
| AU705609B2 (en) | 1999-05-27 |
| US5660824A (en) | 1997-08-26 |
| WO1996037223A1 (en) | 1996-11-28 |
| EP0831902A1 (en) | 1998-04-01 |
| NO975238D0 (no) | 1997-11-14 |
| KR19990014835A (ko) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO975238L (no) | Muskeltrofisk faktor | |
| WO2003022210A3 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
| DE10209822A1 (de) | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid | |
| BG103429A (en) | Methods and compositions for neurone growth stimulation | |
| AU1277688A (en) | Sustained release compositions for parenteral administration and their use | |
| GB2344519B (en) | Sterile therapeutic compositions | |
| CA2169173A1 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
| DE69623644T2 (de) | Verwendung einer desaminierenden oxidase zum backen | |
| DE2006446C3 (de) | Verfahren zur Herstellung von Bleomycin-Antibiotika sowie Bleomycine mit strukturell abgewandelter Seitenkette | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| CA2283676A1 (en) | Stimulation, culture and preservation of pancreatic and other cells | |
| NZ325256A (en) | Imino oxyphenyl acetic acid derivatives, methods and intermediates for their preparation and use thereof | |
| DE2146580A1 (de) | Verfahren zum Herstellen eines lakntzenextraktartigen Produktes als Tabak Aromastoff | |
| DE69902397D1 (de) | Neues verfahren zur kryokonservierung von pflanzen | |
| DE68914660D1 (de) | Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe. | |
| WO2005062942A3 (en) | Novel oligonucleotides and treating cardiac disorders by using the same | |
| DE69124382T3 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| CN110141530A (zh) | 一种变性淀粉组合物及其应用 | |
| DE602005008790D1 (de) | Implantat aus Titan oder einer Titanlegierung und Verfahren zu seiner Oberflächenbehandlung | |
| DE69820911D1 (de) | Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren | |
| UA23999C2 (uk) | Спосіб одержаhhя засобу "біпекс" для лікуваhhя hейрооhкологічhих захворюваhь | |
| ATE421326T1 (de) | Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose | |
| IS5805A (is) | Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum | |
| MD650G2 (ro) | Procedeu de stimulare a creşterii răsadului de tutun | |
| MD2414F1 (en) | Process for vine cultivation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |